The rationale for neoadjuvant radiation therapy in malignant pleural mesothelioma: how smart is SMART?

по Cho, B. C. John
Опубликовано в: Ann Transl Med (2017)

Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors

по Westover, D, Zugazagoitia, J, Cho, B C, Lovly, C M, Paz-Ares, L
Опубликовано в: Ann Oncol (2018)

Outcomes of accelerated hypofractionated radiotherapy in stage i non-small-cell lung cancer

по Yung, T., Giuliani, M.E., Le, L.W., Sun, A., Cho, B.C.J., Bezjak, A., Brade, A., Hope, A.J.
Опубликовано 2012

Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.

по Cho, B C, Shaughnessy, J D, Largaespada, D A, Bedigian, H G, Buchberg, A M, Jenkins, N A, Copeland, N G
Опубликовано 1995

A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens

по Jeung, H-C, Rha, S Y, Cho, B C, Yoo, N C, Roh, J K, Roh, W J, Chung, H C, Ahn, J B
Опубликовано 2006

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy

по Giuliani, M., Sampson, L.R., Wong, O., Gay, J., Le, L.W., Cho, B.C.J., Brade, A., Sun, A., Bezjak, A., Hope, A.J.
Опубликовано в: Curr Oncol (2016)

Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy

по Kim, S-M, Kim, H, Yun, M R, Kang, H N, Pyo, K-H, Park, H J, Lee, J M, Choi, H M, Ellinghaus, P, Ocker, M, Paik, S, Kim, H R, Cho, B C
Опубликовано в: Oncogenesis (2016)

Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy

по Tagawa, Tetsuzo, Anraku, Masaki, Morodomi, Yosuke, Takenaka, Tomoyoshi, Okamoto, Tatsuro, Takenoyama, Mitsuhiro, Ichinose, Yukito, Maehara, Yoshihiko, Cho, B. C. John, Feld, Ronald, Tsao, Ming-Sound, Leighl, Natasha, Bezjak, Andrea, Keshavjee, Shaf, de Perrot, Marc
Опубликовано в: J Thorac Dis (2015)

Dabrafenib in BRAF V600E–Mutant Advanced Non-Small Cell Lung Cancer: an Open-label, Single arm, Multicenter, Phase 2 Trial

по Planchard, David, Kim, Tae Min, Mazieres, Julien, Quoix, Elisabeth, Riely, Gregory, Barlesi, Fabrice, Souquet, Pierre-John, Smit, Egbert F., Groen, Harry J. M., Kelly, Ronan J., Cho, B. C., Socinski, Mark A., Pandite, Lini, Nase, Christine, Ma, Bo, D’Amelio, Anthony, Mookerjee, Bijoyesh, Curtis, C. Martin, Johnson, Bruce E.
Опубликовано в: Lancet Oncol (2016)

A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis

по Yan, Michael, Sigurdson, Samantha, Greifer, Noah, Kennedy, Thomas A. C., Toh, Tzen S., Lindsay, Patricia E., Weiss, Jessica, Hueniken, Katrina, Yeung, Christy, Sugumar, Vijithan, Sun, Alexander, Bezjak, Andrea, Cho, B. C. John, Raman, Srinivas, Hope, Andrew J., Giuliani, Meredith E., Stuart, Elizabeth A., Owen, Timothy, Ashworth, Allison, Robinson, Andrew, de Moraes, Fabio Ynoe, Liu, Geoffrey, Lok, Benjamin H.
Опубликовано в: Cancers (Basel) (2021)